BECOTIDE

This brand name is authorized in Spain, France, Ireland, Italy, South Africa

Active ingredients

The drug BECOTIDE contains one active pharmaceutical ingredient (API):

1 Beclometasone UNII 5B307S63B2 - BECLOMETHASONE DIPROPIONATE

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. Read about Beclometasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BECOTIDE EVOHALER Pressurised inhalation, solution	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA01	Beclometasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 52810
Country: FR	Base de données publique des médicaments	Identifier(s): 61749562, 62013175
Country: IE	Health Products Regulatory Authority	Identifier(s): 58250, 58281, 58297, 58303
Country: IT	Agenzia del Farmaco	Identifier(s): 023378072
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/21.5.1/122, N/21.5.1/0056, N/21.5.1/0057, W/21.5.1/131